Bob Gene Gower - 23 Apr 2026 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Reporting relationship: Director
Issuer ticker: ENSC
Reported as of: 23 Apr 2026
Net transaction value: +$444,169
SEC form: 4
Accepted by SEC: 18 Aug 2026, 06:06:07 UTC
Prior SEC filing: 06 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Bob G. Gower

Key filing fact

Bob Gene Gower filed Form 4 for Ensysce Biosciences, Inc. (ENSC) on 18 Aug 2026.

Key facts

This page summarizes Bob Gene Gower's Form 4 filing for Ensysce Biosciences, Inc. (ENSC).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Aug 2026, 06:06.

Change

Previous filing in this sequence was filed on 06 Mar 2023.
Current net transaction value: +$444,169.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001136466 Primary reporting owner

GOWER BOB G

Relationship: Director
Address: C/O ENSYSCE BIOSCIENCES, INC., 7946 IVANHOE AVENUE, SUITE 201, LA JOLLA
Signature: /s/ Bob G. Gower
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENSC transaction

Common Stock

Purchase

Transaction value: $246,169
Shares: +508,614
Change %: +6259%
Price: $0.4840
Shares after: 516,740
Date: 23 Apr 2026
Ownership: Direct
Footnotes: F1

ENSC transaction

Common Stock

Purchase

Transaction value: $198,000
Shares: +400,000
Change %: +77%
Price: $0.4950
Shares after: 916,740
Date: 07 Aug 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENSC transaction Derivative

Warrant

Conversion of derivative security

Transaction value
Shares: +254,307
Change %: +716%
Price
Shares after: 289,836
Date: 23 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 254,307
Exercise price: $0.4840
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The total of securities reported as beneficially owned reflects two reverse stock splits effected by the Issuer subsequent to the last filing on Form 4 by the Reporting Person.

Footnote F2

Amendment and conversion, without payment of additional consideration, of two senior convertible promissory notes, aggregate principal amount $216,000, issued in 2023 into 254,307 shares of common stock as reported in Table 1 above and a warrant to purchase 254,307 shares of common stock as reported in Table II above. In April 2026, the outstanding principal amount, together with accrued and unpaid interest, was $246,169.